Modern Look at Transverse Myelitis and Inflammatory Myelopathy
Epidemiology of the National Veterans Health Administration Population
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 6, 2021
- Accepted in final form July 22, 2021
- First Published August 31, 2021.
Author Disclosures
- Justin R. Abbatemarco, MD*,
- Jonathan R. Galli, MD*,
- Michael L. Sweeney, MD,
- Noel G. Carlson, PhD,
- Verena C. Samara, MD,
- Haley Davis, MD,
- Stefanie Rodenbeck, MD,
- Ka-Ho Wong, BS, MBA,
- M. Mateo Paz Soldan, MD, PhD,
- John E. Greenlee, MD,
- John W. Rose, MD,
- Alen Delic, MS and
- Stacey L. Clardy, MD, PhD
- Justin R. Abbatemarco, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jonathan R. Galli, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I received the James T Lubin Clinical Scientist award in 2018 from the Siegel Rare Neuroimmune Association which helped fund my fellowship.
NONE
NONE
NONE
NONE
NONE
NONE
- Michael L. Sweeney, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Speakers bureau for Genentech
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Noel G. Carlson, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I am employed by the Department of Veterans Affairs and the University of Utah.
NONE
I have received research support from: Biogen and Astra Zeneca.
I have received funding from The Department of Veterans Affairs Merit Review.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Verena C. Samara, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Haley Davis, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefanie Rodenbeck, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ka-Ho Wong, BS, MBA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- M. Mateo Paz Soldan, MD, PhD,
NONE
NONE
NONE
(1) Journal of Neuroimaging, editorial board, 2021 to present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Biogen, (2) Novartis
(1) National Institutes of Health
NONE
(1) National Multiple Sclerosis Society, (2) Western Institute for Veterans Research
NONE
NONE
NONE
NONE
NONE
NONE
- John E. Greenlee, MD,
NONE
NONE
NONE
1.I serve as Senior Associate Editor for Medlink 2. I serve as Associate Editor for Clinical Neurology and Neurosurgery (without compensation)
NONE
I receive compensation for contributions to Medlink, updated annually. These include chapters on Brain Abscess, Intracranial spinal epidural abscess, Spinal epidural abscess, Intracranial subdural empyema, spinal subdural empyema, Recurrent meningitis, Mycoplasma infections, neonatal meningitis, Progressive multifocal leukoencephalopathy and Infective endocarditis (Dates 2008- 2021). I also received compensation for editing and reviewing chapters for both Medlink and for the Merck Manual.
American Academy of Neurology. Course director and faculty, 2009, 2010, 2011, 2012, 2014
Consultancy as expert witness for Wheeler, Trigg, O'Donnell LLC 2019. Consultancy no longer active.
NONE
NONE
NONE
NONE
United States Department of Veterans Affairs as principal investigator for Merit Review Award 2006-2015 (Merit Reviews do not have individual award numbers)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I reviewed clinical records and gave testimony as an expert witness for the defendant(s) in a case of inadequately treated subdural empyema for the law firm Wheeler, Trigg, & O'Donnell, 2019. I have reviewed clinical records for the law firm Sommers Schwartz, P.C., 2020.
- John W. Rose, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Multiple Sclerosis Society, Guthy Jackson Charitable Foundation, Friends of MS, NIH, Biogen
NIH CoI 2018-2020
NONE
National Multiple Sclerosis Society, (Co PI) 2016 to 2022; Guthy Jackson Charitable Foundation (Co PI) 2016 to 2020, Friends of MS 2017 to 2021.
NONE
NONE
NONE
NONE
NONE
NONE
- Alen Delic, MS and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stacey L. Clardy, MD, PhD
Consulting/Ad Board: Alexion, VielaBio, Genentech, Guidepoint, ExpertConnect, Clarion Healthcare Consulting. (*Majority Fees to U.Utah Development account)
NONE
NONE
Section Editor, Neurology Podcast (July 2018-present) and Neurology Minute (March 2019-present)
NONE
NONE
NONE
Consulting/Ad Board: Alexion, VielaBio, Genentech, Guidepoint, ExpertConnect, Clarion Healthcare Consulting. (*Majority Fees to U.Utah Development account).
NONE
NONE
NONE
Research Support: Alexion, VielaBio. Site investigator: Alexion clinical trial for Eculizumab in Relapsing NMO patients (in extension).
NONE
NONE
Research Support: The Siegel Rare Neuroimmune Association (SRNA), the Barbara Gural Steinmetz Foundation, the Sumaira Foundation for NMO.
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (J.R.A., J.R.G., M.L.S., N.G.C., S.R., K.-H.W., M.M.P.S., J.E.G., J.W.R., A.D., S.L.C.), University of Utah, Salt Lake City; George E. Wahlen Veterans Affairs Medical Center (J.R.G., N.G.C., M.M.P.S., J.E.G., J.W.R., A.D., S.L.C.), Salt Lake City, UT; Department of Neurobiology (N.G.C.), University of Utah, Salt Lake City; PeaceHealth Neurology (V.C.S.), Springfield, OR; and Department of Pathology (H.D.), Duke University Hospital, Durham, NC.
- Correspondence
Dr. Clardy stacey.clardy{at}hsc.utah.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Predictors of recurrence following an initial episode of transverse myelitisDorlan J. Kimbrough, Maureen A. Mealy, Alexandra Simpson et al.Neurology - Neuroimmunology Neuroinflammation, April 24, 2014 -
Article
Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiologyElia Sechi, Eslam Shosha, Jonathan P. Williams et al.Neurology, June 24, 2019 -
Articles
A population-based study of neuromyelitis optica in CaucasiansN. Asgari, S.T. Lillevang, H.P.B. Skejoe et al.Neurology, May 02, 2011 -
Article
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritisSudarshini Ramanathan, Stephen W. Reddel, Andrew Henderson et al.Neurology - Neuroimmunology Neuroinflammation, October 29, 2014